PDCO vs. HSIC, OMI, MCK, COR, CAH, MEDP, TECH, PCVX, SRPT, and PEN
Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Henry Schein (HSIC), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Medpace (MEDP), Bio-Techne (TECH), Vaxcyte (PCVX), Sarepta Therapeutics (SRPT), and Penumbra (PEN). These companies are all part of the "medical" sector.
Patterson Companies vs.
Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.
Henry Schein received 16 more outperform votes than Patterson Companies when rated by MarketBeat users. Likewise, 51.64% of users gave Henry Schein an outperform vote while only 50.63% of users gave Patterson Companies an outperform vote.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
85.4% of Patterson Companies shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 1.9% of Patterson Companies shares are held by insiders. Comparatively, 1.1% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Patterson Companies has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.
Patterson Companies currently has a consensus price target of $26.57, indicating a potential downside of 14.48%. Henry Schein has a consensus price target of $80.09, indicating a potential upside of 3.69%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than Patterson Companies.
Henry Schein has a net margin of 2.51% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.
In the previous week, Henry Schein had 5 more articles in the media than Patterson Companies. MarketBeat recorded 10 mentions for Henry Schein and 5 mentions for Patterson Companies. Henry Schein's average media sentiment score of 0.88 beat Patterson Companies' score of 0.84 indicating that Henry Schein is being referred to more favorably in the news media.
Summary
Henry Schein beats Patterson Companies on 16 of the 19 factors compared between the two stocks.
Get Patterson Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Patterson Companies Competitors List
Related Companies and Tools
This page (NASDAQ:PDCO) was last updated on 2/22/2025 by MarketBeat.com Staff